Amniox Medical, Inc.   Report issue

For profit Phase 4
Founded: Atlanta GA United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2011
NCT03113786
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

amniotic membrane (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1